In May, the Biden administration reversed course and decided to back the idea of waiving intellectual property protections for COVID-19 vaccines.
The move was meant to ensure more of the world can become inoculated. “Extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures,” U.S. Trade Representative Katherine Tai said at the time.
David Ricks, CEO of pharmaceutical giant Eli Lilly (LLY), told Yahoo Finance that “this is a counterproductive move.”
“It just…
Source link
